Search
for
Sort by
Research 571–600 of 1000+
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- BIOLOGICAL ACTIVITY OF ANTIANDROGENS
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- Male pattern baldness: current treatments, future prospects
- Pharmacologic Therapy of Polycystic Ovary Syndrome
- Polycystic Ovarian Syndrome in Adolescents
- Female Pattern Hair Loss
- Disorders of hair in infants and children other than alopecia
- Jagged1 and Epidermal Growth Factor Promoted Androgen-Suppressed Mouse Hair Growth In Vitro and In Vivo
- The role of metformin in the management of polycystic ovary syndrome
- Platelet factor 4 inhibits human hair follicle growth and promotes androgen receptor expression in human dermal papilla cells
- [Androgenetic alopecia in the male. Recent developments].
- The investigation and management of the hirsute woman
- 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy
- Real-World Experience of Clascoterone Cream 1% in Acne Management: Case Series and Canadian Experience
- Spironolactone
- Current Landscape and Emerging Therapies in Hair Loss Treatment for Androgenetic Alopecia
- What’s new in the treatment of hair loss?
- ANDROGENIC ALOPECIA: PATHOGENETIC MECHANISMS AND THERAPEUTIC APPROACHES
- Miscellaneous Steroids
- Identification of hepatic molecular mechanisms of action of alpha-tocopherol using global gene expression profile analysis in rats
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Association of prior 5-α-reductase inhibitor exposure with ICI benefit in metastatic RCC: Multicentre cohort with single-cell immune profiling.
- Minoxidil: effectiveness and prospects for use in the treatment of androgenetic alopecia